CHICAGO, July 18, 2022 /PRNewswire/ -- Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading cloud-based technology, which creates transparency, consistency, and reusability across regulatory dossiers.
Read more at prnewswire.comCelegence acquires Qdossier to bolster its regulatory consultancy services and solutions for the pharmaceutical industry
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
/Lululemon%20Athletica%20inc_%20phone%20and%20website%20by-%20T_Schneider%20via%20Shutterstock.jpg)
/Quantum%20Computing/Image%20by%20Funtap%20via%20Shutterstock.jpg)